Deep Dive into the Therapeutic and Diagnostic Schistosomiasis Disease Market segment for Personalized Patient Care
The Schistosomiasis Disease Market segment can be broadly divided into therapeutics, diagnostics, and vector control. Within the therapeutic segment, praziquantel remains the dominant product, but there is a growing niche for combination therapies that may include artemisinins or other anti-parasitic agents to increase clearance rates. In the diagnostic segment, the market is splitting into...
0 Comments
0 Shares
1100 Views